Skip to main content

Navigation group

Type at least 3 characters
489 articles

Articles

Original Research

Published on 27 Aug 2021

Real-Life Experience With First-Line Therapy Bortezomib Plus Melphalan and Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma Ineligible for High Dose Chemotherapy With Autologous Stem-Cell Transplantation

in Hematology

  • Gabriele Buda
  • Maria Livia Del Giudice
  • Elisabetta Antonioli
  • Francesco Ghio
  • Enrico Orciuolo
  • Riccardo Morganti
  • Francesca Martini
  • Michela Staderini
  • Sara Galimberti
  • Mario Petrini
Real-Life Experience With First-Line Therapy Bortezomib Plus Melphalan and Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma Ineligible for High Dose Chemotherapy With Autologous Stem-Cell Transplantation
Frontiers in Medicine
doi 10.3389/fmed.2021.712070
  • 3,743 views
  • 5 citations